Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Sermorelin structure

Sermorelin

Growth Hormone
Phase 3 Research
70%
Low Risk
1/5

Warnings

May affect blood glucose
Previously FDA-approved, now research only

Contraindications

PregnancyBreastfeedingActive CancerPituitary Tumors

Drug Interactions

GlucocorticoidsInsulin

Possible Side Effects

Injection Site PainFlushingHeadacheDizziness

Legal & Regulatory

FDA Status Not FDA Approved
WADA Status Prohibited in Sport
Prescription Required

Pregnancy

Category X - Contraindicated